Get Live Data

GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS: JPMorgan Raises View On Home Building Sector

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,633.50
Bid: 1,633.50
Ask: 1,634.00
Change: -17.00 (-1.03%)
Spread: 0.50 (0.031%)
Open: 1,650.50
High: 1,658.50
Low: 1,627.50
Prev. Close: 1,650.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: JPMorgan Raises View On Home Building Sector

Fri, 21st Feb 2014 10:17

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
UBS RAISES VODAFONE PRICE TARGET TO 275 (260) PENCE - 'BUY'
----------
UBS CUTS SMITHS GROUP TO 'SELL' ('NEUTRAL') - TARGET 1340 (1450) PENCE
----------
UBS INITIATES IMI WITH 'NEUTRAL' - TARGET 1600 PENCE
----------
EXANE BNP CUTS IMI TO 'UNDERPERFORM' ('OUTPERFORM') - TARGET 1400 (1700) PENCE
----------
BERNSTEIN CUTS TESCO PRICE TARGET TO 280 (300) PENCE - 'UNDERPERFORM'
----------
BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 375 (420) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE CUTS UNILEVER PLC PRICE TARGET TO 2350 (2450) PENCE
----------
EXANE BNP CUTS BAE SYSTEMS PRICE TARGET TO 400 (475) PENCE - 'NEUTRAL'
----------
SOCGEN RAISES BAE SYSTEMS TO 'BUY' ('HOLD') - TARGET 450 (480) PENCE
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1981 (1950) PENCE - 'BUY'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 1550 (1250) PENCE - 'OVERWEIGHT'
----------
CITIGROUP RAISES SPORTS DIRECT PRICE TARGET TO 900 (815) PENCE - 'BUY'
----------
FTSE 250
----------
UBS INITIATES BODYCOTE WITH 'BUY' - TARGET 800 PENCE
----------
UBS INITIATES SPIRAX-SARCO WITH 'BUY' - TARGET 3250 PENCE
----------
UBS INITIATES VESUVIUS WITH 'SELL' - TARGET 440 PENCE
----------
UBS INITIATES MORGAN ADVANCED MATERIALS WITH 'BUY' - TARGET 370 PENCE
----------
UBS INITIATES HALMA WITH 'NEUTRAL' - TARGET 600 PENCE
----------
BARCLAYS RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1460 (1270) P. - 'OVERWEIGHT.'
----------
BARCLAYS RAISES WH SMITH PRICE TARGET TO 1250 (990) PENCE - 'OVERWEIGHT'
----------

JPMORGAN RAISES BOVIS HOMES TO 'NEUTRAL'

------------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 910 (700) PENCE
----------

JPMORGAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL'

------------
JPMORGAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 420 (360) PENCE
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2000 (1450) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES REDROW PRICE TARGET TO 350 (260) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES TAYLOR WIMPEY PRICE TARGET TO 140 (120) PENCE - 'OVERWEIGHT'
----------
ALL-SHARE AND AIM
----------
JPMORGAN CUTS NEW WORLD RESOURCES PRICE TARGET TO 15 (59) PENCE - 'UNDERWEIGHT'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
101112131415161718

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.